Perrigo Announces the Launch of Guaifenesin Extended-Release 600mg Tablets
Perrigo Company (Nasdaq: PRGO) announced that it has initiated shipments of its Guaifenesin Extended-Release Tablets, 600mg (a generic version of Mucinex® 600mg tablets) product. This launch consists of product packaged in bottles to a number of customers. The company expects to initiate its full-scale over-the-counter (OTC) launch of product in blister packaging to its retail and wholesale customers in store brand or own label before the end of its current fiscal year.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.